G1 Therapeutics

G1 Therapeutics, Inc. is a commercial-stage oncology biopharmaceutical company based in Research Triangle Park, NC, focused on developing and commercializing next-generation therapies that improve cancer treatment. In 2021, the company received FDA approval for its first cancer drug after 13 years as a clinical-stage company. G1 Therapeutics is publicly listed and specializes in optimizing chemotherapy regimens.